SG11201504859YA - Peri-carbinols - Google Patents

Peri-carbinols

Info

Publication number
SG11201504859YA
SG11201504859YA SG11201504859YA SG11201504859YA SG11201504859YA SG 11201504859Y A SG11201504859Y A SG 11201504859YA SG 11201504859Y A SG11201504859Y A SG 11201504859YA SG 11201504859Y A SG11201504859Y A SG 11201504859YA SG 11201504859Y A SG11201504859Y A SG 11201504859YA
Authority
SG
Singapore
Prior art keywords
carbinols
peri
Prior art date
Application number
SG11201504859YA
Inventor
Thomas A Jordan
John Clifford Chabala
Ke-Qing Ling
William A Kinney
Original Assignee
Aldeyra Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldeyra Therapeutics Inc filed Critical Aldeyra Therapeutics Inc
Publication of SG11201504859YA publication Critical patent/SG11201504859YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201504859YA 2012-12-20 2013-12-19 Peri-carbinols SG11201504859YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261740197P 2012-12-20 2012-12-20
PCT/US2013/076592 WO2014100425A1 (en) 2012-12-20 2013-12-19 Peri-carbinols

Publications (1)

Publication Number Publication Date
SG11201504859YA true SG11201504859YA (en) 2015-07-30

Family

ID=50979217

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201504859YA SG11201504859YA (en) 2012-12-20 2013-12-19 Peri-carbinols

Country Status (14)

Country Link
US (1) US9604997B2 (en)
EP (1) EP2935220A4 (en)
JP (1) JP2016503797A (en)
KR (1) KR20150118106A (en)
CN (1) CN105073714A (en)
AU (1) AU2013361314A1 (en)
CA (1) CA2896032A1 (en)
CL (1) CL2015001754A1 (en)
HK (1) HK1217325A1 (en)
IL (1) IL239178A0 (en)
MX (1) MX2015007916A (en)
RU (1) RU2015120478A (en)
SG (1) SG11201504859YA (en)
WO (1) WO2014100425A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393768T3 (en) 2005-05-26 2012-12-27 Neuron Systems, Inc Quinoline derivative for the treatment of retinal diseases
CA2894542C (en) 2012-12-21 2023-10-31 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
KR102435676B1 (en) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. Toxic aldehyde related diseases and treatment
US10111862B2 (en) 2013-01-25 2018-10-30 Aldeyra Therapeutics, Inc. Traps in the treatment of macular degeneration
AU2016311158A1 (en) 2015-08-21 2018-04-05 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
KR20180073553A (en) * 2015-08-21 2018-07-02 알데이라 테라퓨틱스, 아이엔씨. Aldehyde conjugates and uses thereof
EP3419633A4 (en) 2016-02-28 2019-10-30 Aldeyra Therapeutics, Inc. Treatment of allergic eye conditions with cyclodextrins
EP3454858A4 (en) 2016-05-09 2020-01-15 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
EP3500256A4 (en) * 2016-08-22 2020-01-08 Aldeyra Therapeutics, Inc. Aldehyde trapping compounds and uses thereof
JP2020511461A (en) 2017-03-16 2020-04-16 アルデイラ セラピューティクス, インコーポレイテッド Polymorphic compounds and their use
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
JP2021533154A (en) 2018-08-06 2021-12-02 アルデイラ セラピューティクス, インコーポレイテッド Polymorphic compounds and their use
CN113056353B (en) 2018-09-25 2022-11-01 奥尔德拉医疗公司 Formulation for treating dry eye
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
KR20230041021A (en) 2020-07-16 2023-03-23 더마반트 사이언시즈 게엠베하 Isoquinoline compounds and their use in the treatment of AhR imbalance

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2086186A (en) 1933-10-10 1937-07-06 Us Rubber Co Treatment of rubber
SU509046A1 (en) 1975-02-21 1984-06-23 Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе Derivatives of 2-carbethoxy-3-aminoindole having antiinflammatory effect and process for preparing same
US4675332A (en) 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
GB8610981D0 (en) 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
AU641052B2 (en) 1990-11-02 1993-09-09 Aventisub Ii Inc. 3-amidoindolyl derivatives
US5668117A (en) 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5493027A (en) 1993-01-22 1996-02-20 Board Of Regents, The University Of Texas System Anticonvulsive agents and uses thereof
US5597823A (en) 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
JP2001508029A (en) 1996-08-01 2001-06-19 ダウ・アグロサイエンス・エル・エル・シー 4-substituted quinoline derivatives having fungicidal and fungicidal activity
DE59813690D1 (en) 1997-05-02 2006-09-28 Schering Ag SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICINAL PRODUCTS
JP2004500308A (en) 1998-03-12 2004-01-08 ノボ ノルディスク アクティーゼルスカブ Modulator of protein tyrosine phosphatase
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
AU1735001A (en) 1999-12-10 2001-06-18 Senju Pharmaceutical Co., Ltd. Cyclodextrin-containing pharmaceutical composition
FR2827599A1 (en) 2001-07-20 2003-01-24 Neuro3D Treating central nervous system disorders, e.g. anxiety, depression, schizophrenia or pain, using new or known 2-substituted quinoline or quinoxaline derivatives having xanthenuric acid modulating action
US20060014786A1 (en) 2002-05-17 2006-01-19 Rajeev Raut Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
US20040242704A1 (en) 2003-03-14 2004-12-02 University Of Washington, Techtransfer - Invention Licensing Stabilized mutant opsin proteins
DE602004030103D1 (en) 2003-04-18 2010-12-30 Advanced Medicine Res Inst MEDIUM FOR THE TREATMENT OF DISEASES TO APPLY TO THE EYE
US20060111318A1 (en) 2003-04-18 2006-05-25 Advanced Medicine Research Institute Agent for treating eye diseases
US7297709B2 (en) 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
US7563906B2 (en) 2003-10-15 2009-07-21 Ube Industries, Ltd. Indazole derivatives
EP1689397A4 (en) 2003-11-20 2007-06-20 Othera Pharmaceuticals Inc Amelioration of macular degeneration and other ophthalmic diseases
US20050197292A1 (en) 2004-01-30 2005-09-08 Glennda Smithson Compositions and methods for treating T-cell mediated pathological conditions
EP1722766A2 (en) 2004-02-17 2006-11-22 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
US20050234018A1 (en) 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
WO2006002473A1 (en) 2004-07-02 2006-01-12 Adelaide Research & Innovation Pty Ltd Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
US20070287716A1 (en) * 2004-10-28 2007-12-13 Hu Essa H Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors
TW200640443A (en) 2005-02-23 2006-12-01 Alcon Inc Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
ES2393768T3 (en) 2005-05-26 2012-12-27 Neuron Systems, Inc Quinoline derivative for the treatment of retinal diseases
ZA200809493B (en) * 2006-04-14 2010-08-25 Prana Biotechnology Ltd Method of treatment of age-related macular degeneration (AMD)
EP2079699A1 (en) * 2006-07-25 2009-07-22 Envivo Pharmaceuticals, Inc. Quinoline derivatives
RU2014151622A (en) 2007-10-05 2015-08-20 Акусела Инк. COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
KR20110044291A (en) 2008-08-12 2011-04-28 서트리스 파마슈티컬즈, 인코포레이티드 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
WO2010133672A1 (en) * 2009-05-20 2010-11-25 Clanotech Ab Derivatives of quinoline-3-carboxylic acid and their medical use
EP2477594A4 (en) 2009-07-15 2013-03-13 Univ Vanderbilt Isoketal scavengers and mitigation of disorders involving oxidative injury
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
CA2782015C (en) 2009-12-11 2020-08-25 Neuron Systems, Inc. Topical ophthalmic compositions and methods for the treatment of macular degeneration
PL2663550T4 (en) 2011-01-12 2017-07-31 Ventirx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
CN103442735B (en) 2011-01-31 2016-11-09 特米拉公司 Active principle for undesirable medical condition in mitigation technique field
KR102435676B1 (en) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. Toxic aldehyde related diseases and treatment
US10111862B2 (en) 2013-01-25 2018-10-30 Aldeyra Therapeutics, Inc. Traps in the treatment of macular degeneration
US10272106B2 (en) 2014-06-04 2019-04-30 Case Western Reserve University Compositions and methods of treating diabetic retinopathy
WO2016085939A2 (en) 2014-11-24 2016-06-02 Case Western Reserve University Compounds and methods of treating ocular disorders

Also Published As

Publication number Publication date
HK1217325A1 (en) 2017-01-06
KR20150118106A (en) 2015-10-21
MX2015007916A (en) 2016-04-07
US9604997B2 (en) 2017-03-28
EP2935220A4 (en) 2016-04-27
CA2896032A1 (en) 2014-06-26
WO2014100425A1 (en) 2014-06-26
CL2015001754A1 (en) 2015-11-06
RU2015120478A (en) 2017-01-25
JP2016503797A (en) 2016-02-08
EP2935220A1 (en) 2015-10-28
AU2013361314A1 (en) 2015-07-02
CN105073714A (en) 2015-11-18
US20150344432A1 (en) 2015-12-03
IL239178A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
DK3327112T3 (en) Agse-deficient stamme
EP2754580A4 (en) Dumptruck
DK2830816T3 (en) Hidtil ukendt coatingkoncept
HK1217325A1 (en) Peri-carbinols
EP2920142A4 (en) Methanofullerenes
EP2812698A4 (en) Dual-acceptor time-resolved-fret
EP2920157A4 (en) Di-macrocycles
EP2873363A4 (en) Diopsimeter
EP2834250A4 (en) Lithiumsilicate
GB201203307D0 (en) Remvox
AU345893S (en) Treehouse
GB201204316D0 (en) Comniview
GB201204245D0 (en) MobiKey
GB201204164D0 (en) Plugstop
GB201204088D0 (en) Tidythatcable
GB201203962D0 (en) Locnlatch
GB201203844D0 (en) Salvacubo
GB201203776D0 (en) Sili-m8
GB201203777D0 (en) Quit-clip
GB201203815D0 (en) Mini-meals
GB201203808D0 (en) MicBooth
GB201203604D0 (en) Envelope-box
GB201203612D0 (en) Ishopfront
GB201203507D0 (en) Keynut
GB201203453D0 (en) TVtidy